Key Considerations in FDA Prelicense Inspections: Ensuring Compliance and Quality in Biomanufacturing
Regulatory agencies increasingly are adopting risk-based inspection strategies to ensure that biological products meet stringent safety, efficacy, and quality standards. US Food and Drug Administration (FDA) prelicense inspections (PLIs) represent a …